Imagen de cubierta local
Imagen de cubierta local
Imagen de Google Jackets

Diseases of the Liver and Biliary Tree / edited by Annarosa Floreani

Colaborador(es): Floreani, Annarosa, editor literario.
Tipo de material: materialTypeLabelE-bookEditor: Cham : Springer Nature, 2021Edición: First edition 2021.Descripción: 1 recurso en línea (VIII, 293 páginas) : 40 ilustraciones, 21 ilustraciones a color.ISBN: 9783030659080.Tema: Hígado -- EnfermedadesRecursos en línea: Acceso a este recurso digital (usuarios Universidad Europea de Valencia)Digital Resources
Contenidos:
Part 1. Congenital biliary abnormalities: Biliary atresia. Congenital cystic lesion of the biliary tree. Biliary hamartomas -- Part 2. Genetic cholangiopathies: Alagille syndrome. Caroli disease. Liver disease in cystic fibrosis. Low-phospholipidic associated cholelithiasis (LPAC syndrome) -- Part 3. Autoimmune cholangiopathies: Primary Biliary Cholangitis. Primary sclerosing cholangitis. IgG4-related cholangitis. Overlap syndromes -- Part 4. Secondary cholangiopathies: Inflammatory cholangitis. Drug-induced cholangiopathies -- Part 5 Neoplasms of the biliary tree:Cholangiocarcinoma -- Part 6. Special topics: Pregnancy and diseases of the biliary tree. Transplant and diseases of the biliary tree.
Resumen: This book provides a comprehensive overview of the diagnosis and management of diseases of the biliary tree. Topics covered include: congenital biliary abnormalities, genetic cholangiopathies, autoimmune cholangiopathies, inflammatory and drug-related cholangiopathies, and cholangiocarcinoma. Given their particular importance (even for clinicians working with adults), pediatric conditions are also examined. In addition, a special section is devoted to pregnancy and diseases of the biliary tree, and to transplants and diseases of the biliary tree. Each chapter offers up-to-date information on the management of the diseases discussed. Moreover, the book addresses new treatments for autoimmune cholestatic liver diseases, reflecting the new therapeutic targets that have recently been discovered. Examples include farnesoid X receptor (FXR) and peroxisome proliferator-activated receptor (PPAR)-agonists, together with new drugs that affect the composition of bile flow. Given its scope, the book offers a valuable guide for a broad range of practitioners.
Valoración
    Valoración media: 0.0 (0 votos)
Existencias
Tipo de ítem Biblioteca actual Colección Signatura topográfica Estado Fecha de vencimiento Código de barras Reserva de ítems
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Valencia Digital Acceso Electrónico (UEV) Ciencias de la Salud RC845 .F56 2021 EB (Navegar estantería(Abre debajo)) Acceso electrónico
Total de reservas: 0

Part 1. Congenital biliary abnormalities: Biliary atresia. Congenital cystic lesion of the biliary tree. Biliary hamartomas -- Part 2. Genetic cholangiopathies: Alagille syndrome. Caroli disease. Liver disease in cystic fibrosis. Low-phospholipidic associated cholelithiasis (LPAC syndrome) -- Part 3. Autoimmune cholangiopathies: Primary Biliary Cholangitis. Primary sclerosing cholangitis. IgG4-related cholangitis. Overlap syndromes -- Part 4. Secondary cholangiopathies: Inflammatory cholangitis. Drug-induced cholangiopathies -- Part 5 Neoplasms of the biliary tree:Cholangiocarcinoma -- Part 6. Special topics: Pregnancy and diseases of the biliary tree. Transplant and diseases of the biliary tree.

This book provides a comprehensive overview of the diagnosis and management of diseases of the biliary tree. Topics covered include: congenital biliary abnormalities, genetic cholangiopathies, autoimmune cholangiopathies, inflammatory and drug-related cholangiopathies, and cholangiocarcinoma. Given their particular importance (even for clinicians working with adults), pediatric conditions are also examined. In addition, a special section is devoted to pregnancy and diseases of the biliary tree, and to transplants and diseases of the biliary tree. Each chapter offers up-to-date information on the management of the diseases discussed. Moreover, the book addresses new treatments for autoimmune cholestatic liver diseases, reflecting the new therapeutic targets that have recently been discovered. Examples include farnesoid X receptor (FXR) and peroxisome proliferator-activated receptor (PPAR)-agonists, together with new drugs that affect the composition of bile flow. Given its scope, the book offers a valuable guide for a broad range of practitioners.

No hay comentarios en este titulo.

para colocar un comentario.

Haga clic en una imagen para verla en el visor de imágenes

Imagen de cubierta local
Compartir